A guideline for the use of blood and blood components in the management of massive haemorrhage

Hdl Handle:
http://hdl.handle.net/10147/83013
Title:
A guideline for the use of blood and blood components in the management of massive haemorrhage
Other Titles:
Issued by the National Blood Users Group
Authors:
National Blood Users Group
Affiliation:
Irish Blood Transfusion Service (IBTS)
Publisher:
Irish Blood Transfusion Service (IBTS)
Issue Date:
Nov-2002
URI:
http://hdl.handle.net/10147/83013
Item Type:
Guideline
Language:
en
Description:
Rapid and continuing loss of blood is life-threatening. Ensuring that tissue oxygenation is maintained at a level consistent with avoidance of critical ischaemic organ damage and irreversible organ failure demands speed and skill. The knowledge base for that skill is the subject of this Guideline. Massive haemorrhage does not easily lend itself to clinical trials. Randomised and controlled trials are extremely difficult to design and conduct and blinding of investigators is clearly impossible. Nevertheless several careful studies have been reported that provide a basis for identifying current best practice in massive haemorrhage. Many questions are unanswered, and may continue to be so. For example controversy persists over which fluids to use for initial resuscitation or maintenance of the intravascular volume. The timing and extent of initial resuscitation in certain types of patients with rapid and severe blood loss have also been questioned. In this setting, an evidence-based Guideline is likely to undergo modification in the future as our understanding of the treatment of severe haemorrhage develops. The requirement for teamwork, early involvement of senior staff and a planned and practised approach is unlikely however to be superseded for a very long time. All hospitals should have protocols for the management of massive haemorrhage, and all clinicians who are likely to deal with massive haemorrhage should be aware of these protocols. Prompt action and clear communication between hospital staff and departments involved in the care of these patients are essential.
Keywords:
BLOOD TRANSFUSION; INFECTION CONTROL

Full metadata record

DC FieldValue Language
dc.contributor.authorNational Blood Users Groupen
dc.date.accessioned2009-09-29T15:46:36Z-
dc.date.available2009-09-29T15:46:36Z-
dc.date.issued2002-11-
dc.identifier.urihttp://hdl.handle.net/10147/83013-
dc.descriptionRapid and continuing loss of blood is life-threatening. Ensuring that tissue oxygenation is maintained at a level consistent with avoidance of critical ischaemic organ damage and irreversible organ failure demands speed and skill. The knowledge base for that skill is the subject of this Guideline. Massive haemorrhage does not easily lend itself to clinical trials. Randomised and controlled trials are extremely difficult to design and conduct and blinding of investigators is clearly impossible. Nevertheless several careful studies have been reported that provide a basis for identifying current best practice in massive haemorrhage. Many questions are unanswered, and may continue to be so. For example controversy persists over which fluids to use for initial resuscitation or maintenance of the intravascular volume. The timing and extent of initial resuscitation in certain types of patients with rapid and severe blood loss have also been questioned. In this setting, an evidence-based Guideline is likely to undergo modification in the future as our understanding of the treatment of severe haemorrhage develops. The requirement for teamwork, early involvement of senior staff and a planned and practised approach is unlikely however to be superseded for a very long time. All hospitals should have protocols for the management of massive haemorrhage, and all clinicians who are likely to deal with massive haemorrhage should be aware of these protocols. Prompt action and clear communication between hospital staff and departments involved in the care of these patients are essential.en
dc.language.isoenen
dc.publisherIrish Blood Transfusion Service (IBTS)en
dc.subjectBLOOD TRANSFUSIONen
dc.subjectINFECTION CONTROLen
dc.titleA guideline for the use of blood and blood components in the management of massive haemorrhageen
dc.title.alternativeIssued by the National Blood Users Groupen
dc.typeGuidelineen
dc.contributor.departmentIrish Blood Transfusion Service (IBTS)en
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.